Enliven Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
KRON
Kronos Bio, Inc. |
$0.87 | $53.65 M | -0.82 | 8 |
CGEM
Cullinan Oncology, Inc. |
$8.16 | $480.97 M | -2.94 | 111 |
CELC
Celcuity Inc. |
$11.81 | $447.20 M | -3.87 | 87 |
GOSS
Gossamer Bio, Inc. |
$1.29 | $294.36 M | -5.89 | 144 |
MACK
Merrimack Pharmaceuticals, Inc. |
$15.15 | $223.97 M | -168.28 | 0 |
MLTX
MoonLake Immunotherapeutics |
$43.50 | $2.76 B | -18.91 | 100 |
GPCR
Structure Therapeutics Inc. |
$21.62 | $1.25 B | -8.39 | 163 |
AVTE
Aerovate Therapeutics, Inc. |
$9.41 | $77.68 M | -0.05 | 4 |
INBX
Inhibrx Biosciences, Inc. |
$15.21 | $220.47 M | 0.13 | 156 |
IMRX
Immuneering Corporation |
$2.77 | $100.22 M | -1.41 | 54 |
CMPX
Compass Therapeutics, Inc. |
$2.38 | $328.42 M | -5.94 | 35 |
NVCT
Nuvectis Pharma, Inc. |
$8.05 | $168.19 M | -7.12 | 13 |
REPL
Replimune Group, Inc. |
$9.49 | $733.09 M | -3.13 | 479 |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.10 | $57.41 M | -0.94 | 47 |
LYRA
Lyra Therapeutics, Inc. |
$10.68 | $14.19 M | -0.18 | 30 |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $342.68 M | -2.3 | 9 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
